News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
250 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21312)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Bunzl Canada’s Intelligent Restroom System Captures Global Interest
Demand for exclusive IoT solution grows in Canada, Europe and Australia
September 19, 2018
·
2 min read
FDA
UTILITY Receives Investigational New Drug Approval from US FDA
UTILITY therapeutics Ltd today announces that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) applications for mecillinam (injectable) and pivmecillinam (oral prodrug).
September 19, 2018
·
3 min read
Deals
Novo Holdings Acquires a 25% Equity Stake in Envirotainer
Envirotainer today announced that Novo Holdings A/S, has agreed to acquire 24.9% of the equity in Envirotainer in partnership with the private equity firm Cinven.
September 19, 2018
·
2 min read
I-Mab Wins Frost & Sullivan “2018 Best R&D Innovator Award (Biopharma Category)”
I-Mab Biopharma announced today that it has been recognized by Forest & Sullivan, the global leading growth consulting company as well as the biggest growth consulting company in China, with the “2018 Best R&D Innovator (Biopharma Category)” award.
September 19, 2018
·
5 min read
Business
Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company
Abzena, plc has signed an antibody humanisation agreement with Tmunity Therapeutics
September 19, 2018
·
4 min read
FDA
OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)
Second Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid and liquid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme
September 19, 2018
·
4 min read
Biotech Bay
The Moore Foundation Doubles Down on Support for Quantum Materials
Boosts basic scientific research with $95 million for the next six years
September 19, 2018
·
5 min read
Business
Zymeworks Names Anthony Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer
Zymeworks Inc. today announced it has named Anthony (Tony) Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer.
September 19, 2018
·
5 min read
Deals
Aralez Pharmaceuticals Enters Into Definitive “Stalking Horse” Purchase Agreements For Substantially All Assets
Transactions valued at an aggregate of U.S. $240 million
September 19, 2018
·
8 min read
Policy
Cepheid Receives CE-IVD clearance for Xpert HCV VL Fingerstick
Enables Hepatitis C Point-of-Care molecular testing and linkage to care
September 19, 2018
·
2 min read
Previous
11 of 25
Next